Nephrocare Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services (NEPHROPLUS) has informed the exchanges that the trading window for dealing in its securities will be closed for designated persons (including their immediate relatives) starting April 1, 2026. The window will reopen 48 hours after the company declares its audited financial results for the quarter and full year ended March 31, 2026. This is a routine compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015. The closure prevents insiders from trading in the stock while they may be in possession of unpublished financial information. Investors should watch for the upcoming Q4 and FY26 audited results announcement, which is expected in late April or May 2026.
No direct impact on retail shareholders — this is a standard insider trading compliance measure. The key catalyst to watch is the forthcoming audited FY26 results, which will trigger the reopening of the trading window and could move the stock.